QuantiFERON-TB Gold In-Tube test for diagnosis of latent tuberculosis (TB) infection in solid organ transplant candidates: A single-center study in an area endemic for TB

Transplant Infectious Disease

Volumn 15, Issue 1, 2013, Pages 90-95

  Ahmadinejad, Z ^a   Azmoudeh Ardalan, F ^a   Razzaqi, M ^b   Davoudi, S ^a   Jafarian, A ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Latent tuberculosis infection; QuantiFERON TB Gold In Tube; Solid organ transplantation; Tuberculin skin test

Indexed keywords

ADULT; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENDEMIC DISEASE; FEMALE; FOLLOW UP; HUMAN; IMMUNE FUNCTION TEST; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; ORGAN TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; QUANTIFERON TB GOLD IN TUBE TEST; SCREENING; TUBERCULIN TEST;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; ORGAN TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; TUBERCULIN TEST; YOUNG ADULT;

EID: 84873431285     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12027     Document Type: Article

References (35)

1. World Health Organization. Global tuberculosis control: 2010 report. [accessed February 2012]. Available at www.who.int/TB.
2. Manuel O, Humar A, Preiksaitis J, et al. Comparison of Quantiferon-TB Gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007; 7 (12): 2797-2801.
3. Malhotra KK, Dash SC, Dhawan IK, Bhuyan UN, Gupta A. Tuberculosis and renal transplantation-observations from an endemic area of tuberculosis. Postgrad Med J 1986; 62: 359-362.
4. Munoz P, Rodriguez C, Bouza E. Mycobacterium tuberculosis infection in recipient of solid organ transplants. Clin Infect Dis 2005; 40 (4): 581-587.
5. Fitzgerald DW, Sterling TR, Hass DW. Mycobacterium tuberculosis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principle and Practice of Infectious Disease (7th edn.). Philadelphia: Churchill Livingstone/Elsevier 2010: 3129-3165.
6. Subramanian A, Doramen S. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S57-S62.
7. Lee SS, Chou KJ, Su IJ, et al. High prevalence of latent tuberculosis infection in patients in end stage renal disease on hemodialysis: comparison of Quantiferon-TB Gold, ELISPOT and tuberculin skin test. Infection 2009; 37 (2): 96-102.
8. Lee SS, Chou KJ, Dou HY, et al. High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test. Clin J Am Soc Nephrol 2010; 5 (8): 1451-1457.
9. Aguado JM, Herrero JA, Gavalda J, et al. Clinical presentation and outcome of tuberculosis in kidney, liver, heart transplant recipients in Spain. Transplantation 1997; 63 (9): 1278-1286.
10. Brighenti S, Andersson J. Local immune responses in human tuberculosis: learning from the site of infection. J Infect Dis 2012; 205 (Suppl 2): S316-S324.
11. Axelsson-Robertson R, Magalhaes I, Parida SK, Zumla A, Maeurer M. The immunological footprint of Mycobacterium tuberculosis T-cell epitope recognition. J Infect Dis 2012; 205 (Suppl 2): S301-S315.
12. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356 (9235): 1099-1104.
13. Bua A, Molicotti P, Delogu G, et al. QuantiFERON TB Gold: a new method for latent tuberculosis infection. New Microbiol 2007; 30 (4): 477-480.
14. Aaqaard C, Brock I, Olsen A, Ottenhoff TH, Weldingh K, Andersen P. Mapping immune reactivity toward Rv2653 and Rv2654: two novel low-molecular-mass antigens found specifically in the Mycobacterium tuberculosis complex. J Infect Dis 2004; 189 (5): 812-819.
15. Hiquchi K, Kawabe Y, Mitarai S, Yoshiyama T, Harada N, Mori T. Comparison of performance in two diagnostic methods for tuberculosis infection. Med Microbiol Immunol 2009; 198 (1): 33-37.
16. Choi JC, Shin JW, Kim JY, Park IW, Choi BW, Lee MK. The effect of previous tuberculin skin test on the follow up examination of whole-blood interferon-gamma assay in the screening of latent tuberculosis infection. Chest 2008; 133 (6): 1415-1420.
17. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361 (9364): 1168-1173.
18. Jeong SJ, Han SH, Kim CO, et al. Predictive factors for indeterminate result on the QuantiFERON test in an intermediate tuberculosis burden country. J Infect 2011; 62 (5): 347-354.
19. Casas S, Munoz L, Moure R, et al. Comparison of the 2-step tuberculin skin test and the QuantiFERON-TB Gold In-Tube test for the screening of tuberculosis infection before liver transplantation. Liver Transplant 2011; 17 (10): 1205-1211.
20. Fan L, Chen Z, Hao XH, Hu ZY, Xiao HP. Interferon-gamma release assays for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. FEMS Immunol Med Microbiol 2012; 65 (3): 456-466.
21. Shah M, Dipietro D, Greenbaum A, et al. Programmatic impact of QuantiFERON-TB Gold In-tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic. PLoS ONE 2012; 7 (5): e36551.
22. Kobashi Y, Sugio T, Mouri K, Obase Y, Miyashita N, Oka N. Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice. Eur Respir J 2009; 33 (4): 812-815.
23. Winthrop KL, Nyendak M, Calvet H, et al. Interferon-gamma release assay for diagnosis of Mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol 2008; 3 (5): 1357-1363.
24. Triverio PA, Bridevaux PO, Rowx-Lombard P, et al. Interferon-gamma release assay versus tuberculin skin test for detection of latent tuberculosis in chronic hemodialysis patients. Nephrol Dial Transplant 2009; 24 (6): 1952-1956.
25. Seyhan EC, Sökücü S, Altin S, et al. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients. Transpl Infect Dis 2010; 12 (2): 98-105.
26. Pavoni M, Biagetti C, Dal Monte P, et al. Usefulness of the Quantiferon-TB Gold In-Tube test for detecting latent tuberculosis infection in patients with cirrhosis candidate for orthotopic liver transplantation. Digest Liver Dis 2007; 39 (10): A39-A40.
27. Khosroshahi HT, Beiglu LB, Shoja EA, Hassan AP. Tuberculin testing of kidney recipients and donors before transplantation. Transplant Proc 2006; 38 (7): 1982-1984.
28. Kim EY, Lim JE, Jung JY, et al. Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population. BMC Infect Dis 2009; 9: 207.
29. Kobashi Y, Mouri K, Obase Y, Fukuda M, Miyashita N, Oka M. Clinical evaluation of Quantiferon-TB Gold for immunocompromised patients. Eur Respir J 2007; 30 (5): 945-950.
30. Pratt A, Nicholl K, Kay L. Use of the Quantiferon-TB Gold test as part of a screening program in patients with RA under consideration for treatment with anti-TNF-alpha agents: the Newcastle (UK) experience. Rheumatology (Oxford) 2007; 46 (6): 1035-1036.
31. Porsa E, Cheng L, Seale MM, et al. Comparison of a new ESAT-6/CFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population. Clin Vaccine Immunol 2006; 13 (1): 53-58.
32. Mazurek GH, Lobue PA, Daley CL, et al. Comparison of a whole-blood interferon-gamma assay with tuberculin skin test for detecting latent tuberculosis infection. JAMA 2001; 286 (14): 1740-1747.
33. Kang YA, Lee HW, Yoon HI, et al. Discrepancy between the tuberculin skin test and whole-blood interferon assay for the diagnosis of latent tuberculosis infection in an indeterminate tuberculosis-burden country. JAMA 2005; 293 (22): 2756-2761.
34. Kariminia A, Sharifnia Z, Aghakhani A, et al. Comparison of Quantiferon-TB Gold test to tuberculin skin test for detecting latent tuberculosis infection in a high-incidence area containing BCG-vaccinated population. J Eval Clin Pract 2007; 15 (1): 148-151.
35. Kobashi Y, Obase Y, Fukuda M, Yoshida K, Miyashita N, Oka M. Clinical reevaluation of the Quantiferon-TB Gold In-Tube as a diagnostic method for differentiating active TB from nontuberculosis mycobacterium. Clin Infect Dis 2006; 43 (12): 1540-1546.